Merck & Co., Inc.
MRK
$131.49
$0.770.59%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 1.40% | 0.58% | 2.00% | 7.21% | 21.72% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.40% | 0.58% | 2.00% | 7.21% | 21.72% |
| Cost of Revenue | -7.50% | -8.52% | -8.01% | -0.52% | 27.43% |
| Gross Profit | 5.04% | 4.40% | 6.22% | 10.42% | 19.53% |
| SG&A Expenses | -0.12% | -1.20% | -0.27% | 1.92% | 0.91% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 42.81% | 21.73% | 26.83% | 4.94% | 11.52% |
| Operating Income | -75.95% | -47.16% | -51.53% | 12.24% | 46.81% |
| Income Before Tax | -88.51% | -55.77% | -70.79% | -3.30% | 18.48% |
| Income Tax Expenses | -21.13% | 87.59% | 22.17% | 19.11% | 26.04% |
| Earnings from Continuing Operations | -97.40% | -69.86% | -81.24% | -6.26% | 17.55% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -50.00% | -18.18% | -30.00% | -150.00% | 38.46% |
| Net Income | -97.49% | -69.80% | -81.24% | -8.11% | 11.27% |
| EBIT | -75.95% | -47.16% | -51.53% | 12.24% | 46.81% |
| EBITDA | -64.42% | -39.24% | -42.52% | 11.83% | 42.18% |
| EPS Basic | -97.48% | -69.86% | -81.23% | -8.30% | 11.19% |
| Normalized Basic EPS | -81.55% | -48.18% | -52.43% | 13.89% | 51.78% |
| EPS Diluted | -97.68% | -70.07% | -81.34% | -8.33% | 11.18% |
| Normalized Diluted EPS | -81.68% | -48.34% | -52.61% | 13.76% | 51.65% |
| Average Basic Shares Outstanding | 0.19% | 0.31% | 0.30% | 0.20% | 0.07% |
| Average Diluted Shares Outstanding | 0.02% | 0.30% | 0.32% | 0.33% | 0.15% |
| Dividend Per Share | 5.80% | 5.88% | 5.97% | 6.06% | 6.15% |
| Payout Ratio | 41.23% | 2.52% | 4.66% | 0.15% | -0.05% |
